Related Experiment Videos
Synthesis, properties and microemulsion formulation of ibuprofen eugenol ester
1School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, People's Republic of China.
Die Pharmazie
|January 10, 2006
Summary
A novel ibuprofen prodrug, ibuprofen-eugenol ester (IEE), was developed to reduce anti-inflammatory drug side effects. A microemulsion formulation significantly enhanced IEE solubility and ibuprofen bioavailability, suggesting a promising oral delivery system.
Area of Science:
- Medicinal Chemistry
- Pharmaceutics
- Drug Delivery Systems
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen are widely used but associated with gastrointestinal side effects.
- Developing effective drug delivery systems for poorly water-soluble compounds remains a significant challenge in pharmaceutical science.
Purpose of the Study:
- To synthesize and characterize a novel ibuprofen prodrug, ibuprofen-eugenol ester (IEE), to mitigate ibuprofen's side effects.
- To develop and evaluate a microemulsion formulation for enhancing the solubility and oral bioavailability of IEE.
Main Methods:
- Synthesis and structural confirmation of ibuprofen-eugenol ester (IEE) using spectroscopic techniques (IR, 1H NMR, MS).
- Assessment of IEE stability across a range of pH values and its susceptibility to enzymatic hydrolysis.
- Characterization of a microemulsion system for IEE, including stability, droplet size distribution (DSD), and solubilization capacity.
- Pharmacokinetic evaluation by comparing the area under the curve (AUC) of ibuprofen from the IEE prodrug versus oral ibuprofen suspension in rats.
Main Results:
- Ibuprofen-eugenol ester (IEE) was successfully synthesized as a stable, amorphous solid.
- IEE demonstrated stability over a broad pH range (1.1-9.96) but was readily hydrolyzed by rat plasma and liver enzymes.
- The optimized microemulsion formulation exhibited a 21,000-fold increase in IEE solubility compared to water.
- The prodrug formulation resulted in a significant increase in the AUC of ibuprofen compared to oral ibuprofen suspension.
Conclusions:
- The synthesis of the ibuprofen prodrug (IEE) is a viable strategy to potentially reduce the side effects associated with conventional ibuprofen.
- The developed microemulsion system shows promise as an effective oral dosage form for improving the delivery of poorly water-soluble drugs like IEE.
- This approach offers a potential pathway for enhancing the therapeutic efficacy and patient compliance for ibuprofen therapy.